Pages that link to "Q1813737"
Jump to navigation
Jump to search
The following pages link to macular retinal edema (Q1813737):
Displaying 50 items.
- bevacizumab (Q413299) (← links)
- ranibizumab (Q414270) (← links)
- dexamethasone (Q422252) (← links)
- triamcinolone (Q1074056) (← links)
- aflibercept (Q4689286) (← links)
- (Q12636063) (redirect page) (← links)
- cystoid macular edema (Q18556331) (← links)
- diabetic macular edema (Q18558081) (← links)
- Irvine–Gass syndrome (Q19597605) (← links)
- Ocular Complications of Diabetes and Therapeutic Approaches (Q26749412) (← links)
- Central Retinal Vein Occlusion: A Review of Current Evidence-based Treatment Options (Q26767089) (← links)
- Clinical Trials in Branch Retinal Vein Occlusion (Q26767092) (← links)
- Updates on the Clinical Trials in Diabetic Macular Edema (Q26767100) (← links)
- Intravitreal corticosteroids in diabetic macular edema: Pharmacokinetic considerations (Q26782198) (← links)
- The role of aflibercept in the management of diabetic macular edema (Q26798348) (← links)
- Retinal Imaging of Infants on Spectral Domain Optical Coherence Tomography (Q26801880) (← links)
- Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME) (Q26823985) (← links)
- The diagnostic function of OCT in diabetic maculopathy (Q26866032) (← links)
- Optical coherence tomography imaging of macular oedema (Q26991542) (← links)
- Insulin use and risk of diabetic macular edema in diabetes mellitus: a systemic review and meta-analysis of observational studies (Q27010850) (← links)
- Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets (Q27014620) (← links)
- Spectral-domain optical coherence tomography for macular edema (Q27016124) (← links)
- Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory (Q28070894) (← links)
- Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines (Q28075473) (← links)
- Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention (Q28076321) (← links)
- Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report (Q28079912) (← links)
- Diabetic retinopathy and systemic factors (Q28082046) (← links)
- Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema (Q28292764) (← links)
- Laser treatment for diabetic macular edema in the 21st century (Q30436884) (← links)
- Primary treatment of diabetic macular edema (Q33463319) (← links)
- Noninvasive Retinal Markers in Diabetic Retinopathy: Advancing from Bench towards Bedside (Q33608021) (← links)
- Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis (Q33910289) (← links)
- Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review (Q34269588) (← links)
- The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review (Q34378757) (← links)
- Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema (Q34758061) (← links)
- Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review (Q35036495) (← links)
- Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review (Q35059037) (← links)
- Combined therapy for diabetic macular edema (Q35067115) (← links)
- Anti-VEGF for the management of diabetic macular edema (Q35151008) (← links)
- Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment (Q35238074) (← links)
- Updates in the management of diabetic macular edema (Q35578747) (← links)
- Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials (Q35594036) (← links)
- Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa - a first case report and short review of the literature (Q35618296) (← links)
- Comparative efficacy and safety of approved treatments for macular oedema secondary to branch retinal vein occlusion: a network meta-analysis (Q35655005) (← links)
- Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review. (Q35724171) (← links)
- Cystoid macular edema associated with preservative-free latanoprost after uncomplicated cataract surgery: case report and review of the literature (Q36315512) (← links)
- A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders (Q36379671) (← links)
- Treatment of edematous diabetic retinopathy (apropos of 51 cases) (Q36439238) (← links)
- Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review (Q37523465) (← links)
- Treatments for macular oedema following central retinal vein occlusion: systematic review. (Q37590692) (← links)